Le Lézard
Classified in: Health, Business
Subjects: CON, LIC

Univar and ABITEC Corp. Announce Multi-Year Distribution Agreement for Health and Wellness Industries


DOWNERS GROVE, Ill., Feb. 12, 2018 /PRNewswire/ -- Univar Inc. (NYSE: UNVR) ("Univar"), a global chemical and ingredient distributor and provider of value-added services, together with ABITEC Corp. have recently reached a distribution agreement for the CAPMUL®, CAPTEX®, CAPROL®, ACCONON®, STEROTEX®, NUTRI SPERSE®, HYRDO-KOTE® and PURECO® product lines in Canada, effective February 1, 2018.

Univar, logo. (PRNewsFoto/Univar) (PRNewsfoto/Univar Inc.)

Owned by Associated British Foods (ABF), ABITEC Corporation is a division of ABF Ingredients. As a world leader in the development and production of lipids and specialty ingredients, ABITEC creates its products primarily from renewable sources. In the pharmaceutical market, these products are used for a wide-array of applications including: solubilization, emulsification and lubrication to improve drug delivery and enhance bioavailability. In the nutraceutical market, these products are used in a number of health applications including sports nutrition and performance, as well as weight management.

This agreement expands Univar's specialty portfolio to provide customers with important and relevant solutions that will help to overcome some of the most intricate formulating issues facing the pharmaceutical and nutraceutical industries today. Customers in these markets will benefit from the combined value of ABITEC's specialty lipid product portfolio and Univar's safety, supply chain, and formulation expertise.

"We are excited to collaborate with ABITEC, which further enhances our portfolio of highly-functional ingredients for the pharmaceutical and nutraceutical industries, both of which, we have identified as strategic growth industries for Univar," said Willy St. Cyr, Univar's vice president of product and industry development. He further added, "ABITEC's superior product portfolio coupled with Univar's technical expertise will help provide customers next generation solutions to today's most complex formulation challenges. ABITEC's heavy reliance on renewable resources also aligns well with industry megatrends and Univar's focus on sustainability."  

Dr. John Tillotson, technical business director at ABITEC, commented, "ABITEC is pleased to embark on this partnership with Univar to market and distribute ABITEC's highly-functional line of pharmaceutical and nutraceutical excipients throughout Canada.  Univar has a long-standing reputation for their strong capabilities in the technical distribution of highly-functional products in the market, and this relationship offers strong support for ABITEC's business and growth in Canada."

About Univar
Founded in 1924, Univar (NYSE: UNVR) is a global chemical and ingredient distributor and provider of value-added services, working with leading suppliers worldwide. Supported by a comprehensive team of sales and technical professionals with deep specialty and market expertise, Univar operates hundreds of distribution facilities throughout North America, Western Europe, Asia-Pacific and Latin America. Univar delivers tailored customer solutions through a broad product and services portfolio sustained by one of the most extensive industry distribution networks in the world. For more information, visit www.univar.com.

About ABITEC Corporation
ABITEC Corporation is part of ABF Ingredients and is headquartered in Columbus, Ohio, US with two manufacturing sites in the Midwest. ABITEC specializes in the manufacturing and distribution of specialty lipid ingredients for use in the pharmaceutical, nutraceutical, and specialty chemical markets.

In addition, ABITEC offers contract and toll manufacturing services for customers looking to develop and manufacture new oleochemical molecules or blend/toll-manufacture an established product. For more information, visit www.abiteccorp.com

 

 

 

SOURCE Univar Inc.


These press releases may also interest you

at 21:00
OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today published a report titled 'Unlocking the Infinite Potential of Crypto and AI.' The report explores the convergence of AI and crypto, a major trend in...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:45
The "Austria Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs on Social Commerce Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics - Q1 2024 Update" report has been added...

at 20:40
Osisko Development Corp. ("Osisko Development" or the "Company") reports its financial and operating results for the three and twelve months ended December 31, 2023 ("Q4 2023"). Q4 2023 HIGHLIGHTS Operating, Financial and Corporate Updates: 2,090...

at 20:39
TSX VENTURE COMPANIES BULLETIN V2024-0926 VALLEYVIEW RESOURCES LTD. ("VVR")BULLETIN TYPE:  Resume TradingBULLETIN DATE: March 28, 2024TSX Venture Tier 2 Company Reference is made to our bulletin dated March 26, 2024 with respect to the listing of the...

at 20:30
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sonder Holdings Inc. resulting from allegations that Sonder may have issued materially misleading business...



News published on and distributed by: